Eu Yan Sang’s full-year profit plunges 70% to $4.56m

Macro headwinds trumped traditional medicine.

Traditional medicine company Eu Yan Sang reported a 70% drop in net profit for the financial year that ended on June 30.

Eu Yan Sang raked in $4.56m in profits in FY15, compared to 15.03m in the previous financial year.

Its suite of traditional products faltered in the face of intensifying regional headwinds, such as political standoffs in Malaysia and Hong Kong, travel restrictions to Hong Kong, and currency devaluation in Malaysia and Australia.

“The fragile political and business environments in our key markets particularly Hong Kong and Malaysia will continue to pose operating challenges for the Group in the next 12 months,” said Richard Eu, Group Chief Executive Officer.